Adebrelimab Combined With Nab-paclitaxel, Oxaliplatin and Tegafur (AOS) for Perioperative Treatment of Locally Advanced Resectable GC/GEJ
Clinical trial NCT06808971 · RECRUITING
Trial details
- NCT number
- NCT06808971
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-28
- Primary completion
- 2026-12-31
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.